Clinical Trial Update: Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial comparing azilsartan medoxomil to valsartan in Chinese participants with essential hypertension has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Azilsartan medoxomil (azilsartan medoxomil)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Takeda | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2019-02-11